Home > Back to Publisher > Report Information

Influenza Vaccine Market Opportunities and Challenges: Worldwide Forecast

Renub Research
January 5, 2012
80 Pages - SKU: RNBR6743344

Abstract Table of Contents Search inside this report Related Reports

Countries covered: Global

Influenza Vaccine Market Opportunities and Challenges: Worldwide Forecast

Influenza Vaccine Market Overview

Last few years have seen renewed interest in the vaccines market, overcoming the prevailing view that vaccines are a low-margin business with high barriers to entry. The flu vaccines market has been at the forefront of this trend, partially fuelled by the fear of an impending pandemic. As a result global influenza vaccine market has experienced phenomenal growth in recent years at a compound annual growth rate of more than 65% between 2008 and 2010. This growth was mainly driven by the global spread of H1N1 influenza. But in the year 2011 H1N1 pandemic flu vaccine market declined due to waning threat of swine flu disease. However seasonal influenza vaccine market is predicted to grow year on year and cross US$ 4 Billion by 2015.

From our research findings Unites States is the largest market for influenza vaccine market in 2010. In seasonal influenza vaccine brands like Fluarix & Flulaval had highest sales for 2010. Unlike some other pharmaceutical products, influenza vaccines are equally important in both developed and developing nations. In the developing countries, dealing with infectious diseases remains the highest priority in healthcare. It is predicted that in the next 5-6 years seasonal influenza vaccine sales would increase significantly.

Renub Research report entitled "Influenza Vaccine Market Opportunities and Challenges: Worldwide Forecast" critically examines the influenza vaccines market through a comprehensive review of information. This report provides market prospects, Key products detailed sales forecasts, discussions of pipeline developments and analyses of commercial drivers and challenges, including revenue of key players from seasonal and H1N1 influenza vaccine as well as Strengths and Weakness analysis of key players in influenza vaccine segment.

This report examines the following markets for influenza vaccines:

Global Influenza vaccine market (2005 - 2015)
Global Seasonal influenza vaccine market has been covered from (2003 - 2015)
Global Swine Flu (H1N1) influenza vaccine market has been covered from (2009 - 2012)
Top 7 Countries (United States, Germany, France, Italy, Spain, United Kingdom, Japan) seasonal vaccine market data from (2005 - 2015)
Top Brands Seasonal influenza vaccine market performance (Fluarix, Afluria, Flumist, Influvac) market performance and forecast
Top companies Swine Flu vaccine market performance (AstraZeneca, GlaxoSmithKline, Novartis, Sanofi-Pasteur)

Companies Analysis

This section covers the key facts about the major companies that play an important role in Influenza Vaccine Market. The companies analyzed in this section are - GlaxoSmithKline, AstraZeneca, Novartis AG and Sanofi Pasteur. All the companies have been analyzed from three headings

1) Revenue of the company from influenza vaccines (swine flu & seasonal flu)
2) Strength of the company in influenza vaccine market
3) Weakness of the company in influenza vaccine market

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 100 paid databases.

1. Executive Summary
2. Worldwide Influenza Vaccine & Future Market: 2.1 Worldwide Seasonal Influenza Vaccine & Future Market; 2.2 Global Swine Flu (H1N1) Influenza Vaccine & Future Market; 2.3 Merger and Acquisition in Influenza Vaccine Market
3. Geographical Distribution - Seasonal Influenza Vaccine Market (2005 to 2015): 3.1 United States Seasonal Influenza Vaccine Market; 3.2 Germany Seasonal Influenza Vaccine Market; 3.3 France Seasonal Influenza Vaccine Market; 3.4 Italy Seasonal Influenza Vaccine Market; 3.5 Spain Seasonal Influenza Vaccine Market; 3.6 United Kingdom Seasonal Influenza Vaccine Market; 3.7 Japan Seasonal Influenza Vaccine Market
4. Worldwide - Seasonal Influenza Vaccine Brand Market & Forecast Pipeline Analysis: 4.1 Fluarix & Flulaval - Sales Performance & Forecast; 4.2 Afluria - Past, Present and Future Sales Performance; 4.3 FluMist - Past, Present & Future Sales Performance; 4.4 Influvac - Sales Performance & Future Forecast
5. Swine Flu Vaccine Market Analysis - Competitive Landscape: 5.1 AstraZeneca Swine Flu Vaccine Sales Performance; 5.2 GlaxoSmithKline Swine Flu Vaccine Sales Performance; 5.3 Novartis Swine Flu Vaccines Sales Performance; 5.4 Sanofi-Pasteur Swine Flu Vaccine Sales Performance
6. Growth Drivers in the Influenza Vaccines Market: 6.1 Growing Prevalence of Influenza; 6.2 Emerging Vaccine Technologies; 6.3 Effective Communication Strategies; 6.4 Compliance with Vaccination; 6.5 Vaccines most Cost Effective Means of Disease Prevention
7. Challenges for Influenza Vaccine Market: 7.1 Barriers to Optimal use of Licensed Vaccines; 7.2 Complexity of Influenza Vaccine Development & Approval System Thwarts Product Development; 7.3 Shortening the Timeline for Vaccine Development
8. Company Analysis: 8.1 GlaxoSmithKline; 8.2 AstraZeneca; 8.3 Novartis AG; 8.4 Sanofi Pasteur
List of Figures:: Figure 2 1: Worldwide - Influenza Vaccine Market (Million US$), 2005 - 2010; Figure 2 2: Worldwide - Forecast for Influenza Vaccine Market (Million US$), 2011 - 2015; Figure 2 3: Worldwide - Seasonal Influenza Vaccine Market (Million US$), 2005 - 2010; Figure 2 4: Worldwide - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2011 - 2015; Figure 2 5: Worldwide - Swine Flu (H1N1) Influenza Vaccine Market & Forecast (Million US$), 2009 - 2011; Figure 3 1: United-States - Seasonal Influenza Vaccine Market (Million US$), 2005 - 2010; Figure 3 2: United States - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2011 - 2015; Figure 3 3: Germany - Seasonal Influenza Vaccine Market (Million US$), 2005 - 2010; Figure 3 4: Germany - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2011 - 2015; Figure 3 5: France - Seasonal Influenza Vaccine Market (Million US$), 2005 - 2010; Figure 3 6: France - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2011 - 2015; Figure 3 7: Italy - Seasonal Influenza Vaccine Market (Million US$), 2005 - 2010; Figure 3 8: Italy - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2011 - 2015; Figure 3 9: Spain - Seasonal Influenza Vaccine Market (Million US$), 2005 - 2010; Figure 3 10: Spain - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2011 - 2015; Figure 3 11: United Kingdom - Seasonal Influenza Vaccine Market (Million US$), 2005 - 2010; Figure 3 12: United Kingdom - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2011 - 2015; Figure 3 13: Japan - Seasonal Influenza Vaccine Market (Million US$), 2005 - 2010; Figure 3 14: Japan - Forecast for Seasonal Influenza vaccine Market (Million US$), 2011 - 2015; Figure 4 1: Worldwide - Fluarix & Flulaval Vaccine Market (Million US$), 2007 - 2010; Figure 4 2: Worldwide - Forecast for Fluarix & Flulaval Vaccine Market (Million US$), 2011 - 2015; Figure 4 3: Worldwide - Afluria Vaccine Market (Million US$), 2008 - 2010; Figure 4 4: Worldwide - Forecast for Afluria Vaccine Market (Million US$), 2011 - 2015; Figure 4 5: Worldwide - Flumist Vaccine Market (Million US$), 2007 - 2010; Figure 4 6: Worldwide - Forecast for Flumist Vaccine Market (Million US$), 2011 - 2015; Figure 4 7: Worldwide - Influvac Vaccine Market (Million US$), 2006 - 2009; Figure 5 1: Astrazeneca - Swine Flu Vaccine Sales Performance & Future forecast (Million US$), 2009 - 2011; Figure 5 2: GSK - Swine Flu Vaccine Sales Performance & Future Forecast (Million US$), 2009 - 2011; Figure 5 3: Novartis - Swine Flu Vaccine Sales Performance & Future forecast (Million US$), 2009 - 2010; Figure 5 4: Sanofi Pasteur - Swine Flu Vaccine Sales Performance (Million US$), 2008 - 2010; Figure 9 1: Sanofi Pasteur - Influenza Vaccine Revenue (Million US$), 2007 - 2010
List of Tables:: Table 2 1: Worldwide - Pandemic Influenza Vaccine Dose Orders (Million), 2009; Table 2 2: Worldwide - M&A Influenza Vaccine (Million US$), 2003, 2005, 2007, 2009 & 2010; Table 3 1: United States - Population (Million), 2005 - 2015, 2020, 2025, 2030, 2035, 2040, 2045 & 2050; Table 3 2: Germany - Population (Million), 2005 - 2015, 2020, 2025, 2030, 2035, 2040, 2045 & 2050; Table 3 3: France - Population (Million), 2005 - 2015, 2020, 2025, 2030, 2035, 2040, 2045 & 2050; Table 3 4: Italy - Population (Million), 2005 - 2015, 2020, 2025, 2030, 2035, 2040, 2045 & 2050; Table 3 5: Spain - Population (Million), 2005 - 2015, 2020, 2025, 2030, 2035, 2040, 2045 & 2050; Table 3 6: United Kingdom - Population (Million), 2005 - 2015, 2020, 2025, 2030, 2035, 2040, 2045 & 2050; Table 3 7: Japan - Population (Million), 2005 - 2015, 2020, 2025, 2030, 2035, 2040, 2045 & 2050; Table 6 1: United States H1N1 - Related Hospitalizations and Deaths, By Age Group, April 2009 - February 13, 2010; Table 6 2: Improvement Strategies or Requirements - the Joint Commission and the Project’s Collaborating Organizations; Table 6 3: Seasonal Influenza Vaccination Compliance; Table 6 4: Pandemic Flu Vaccination Compliance; Table 6 5: Major Literature Findings Relevant to Influenza; Table 8 1: GlaxoSmithKline - Influenza Vaccine Revenue (Million US$), 2007 - 2010; Table 8 2: AstraZeneca - Influenza Vaccine Revenue (Million US$), 2007 - 2010

More Global Pandemic Vaccines Reports

Human Vaccines by Global Industry Analysts
This report analyzes the worldwide markets for Prophylatic Human Vaccines in US$ Million by the following Product Segments: Pediatric Prophylactic Vaccines and Adult Prophylactic Vaccines. ...

Global Influenza Vaccine Market Analysis by RNCOS
Influenza vaccines are considered as an optimum source of prevention from diseases caused by flu virus. Since the H1N1 pandemic, worldwide authorities have started taking ...

World Influenza Vaccines Market 2011-2021 by Visiongain
Are you looking for influenza vaccine market data - answers to benefit your work? Our new report shows you revenue prospects for the manufacture and ...

Vaccines Review and Outlook 2010 by PharmaLive Special Reports
The global vaccine market is expected to achieve $34 billion in sales by 2012. With an estimated annual growth rate of 14% during the next ...

Vaccines 2010: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry by Kalorama Information
Vaccines have been one of the faster growing areas of the pharmaceutical industry, and during a troubling series of years, they have been the superstars ...

See all reports like this >>

Influenza Vaccine Market Opportunities and Challenges: Worldwide Forecast

Share this report

Other tasks

Research Assistance

Related Markets

Pandemic Vaccines Reports

Free Alert Me service